Zolmitriptan Articles
Zeneca Nine-Month Sales Decline
30 October 1997
Zomig Effective In Menstrual Migraine
30 October 1997
Zeneca's Zomig Approved In Additional Countries
18 August 1997
Zeneca Sees Strong Growth Against The Odds
8 August 1997
Zeneca Invests L10m In Zolmitriptan Manufacture
7 August 1997
New Migraine Drugs Featured At IHS Meeting
19 June 1997
Upbeat UK Companies At Goldman Sachs Conference
17 June 1997
First Launch For Naratriptan
19 May 1997
European And London Stock Comment
21 April 1997
First Launch Of Zeneca's Zomig In The UK
9 April 1997
Sweden Approves Zeneca's Zomig
25 March 1997
Product Launch Costs Restrain Zeneca's Margins
17 March 1997
Zeneca Files For 311C90 Approval
2 December 1996
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
